- Home
- OBIO vs GPRO Comparison
OBIO vs GPRO Comparison
Compare OBIO & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OBIO | GPRO |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 282.4M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | OBIO | GPRO |
|---|---|---|
| Price | $4.19 | $1.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 202.4K | ★ 2.8M |
| Earning Date | 11-10-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,818,000.00 | ★ $650,751,000.00 |
| Revenue This Year | $35.75 | N/A |
| Revenue Next Year | $3.07 | $12.41 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $2.20 | $0.40 |
| 52 Week High | $6.30 | $3.05 |
Technical Indicators
Market Signals| Indicator | OBIO | GPRO |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 37.31 |
| Support Level | $4.07 | $1.55 |
| Resistance Level | $4.37 | $1.61 |
| Average True Range (ATR) | 0.25 | 0.09 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 16.80 | 0.00 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.